Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
96(40), P. 15915 - 15923
Published: Sept. 26, 2024
Accurate
monitoring
of
base
excision
repair
(BER)
activity
in
cancer
cells
is
critical
for
advancing
the
comprehension
DNA
processes,
gaining
insights
into
development,
and
guiding
treatment
strategies.
However,
current
assay
techniques
assessing
BER
face
challenges
due
to
heterogeneous
origins
diversity
enzymes.
In
this
work,
we
present
a
hi
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: July 27, 2024
Companion
diagnostics
using
biomarkers
have
gained
prominence
in
guiding
radiotherapy.
However,
biopsy-based
techniques
fail
to
account
for
real-time
variations
target
response
and
tumor
heterogeneity.
Herein,
we
design
an
activated
afterglow/MRI
probe
as
a
companion
tool
dynamically
assessing
biomarker
apurinic/apyrimidinic
endonuclease
1(APE1)
during
radiotherapy
vivo.
We
employ
ultrabright
afterglow
nanoparticles
ultrasmall
FeMnOx
dual
contrast
agents,
significantly
broadening
signal
change
range
enhancing
the
sensitivity
of
APE1
imaging
(limit
detection:
0.0092
U/mL
0.16
MRI).
devise
longitudinally
transversely
subtraction-enhanced
(L&T-SEI)
strategy
markedly
enhance
MRI
signal-to-noise
ratio
between
normal
tissue
living
female
mice.
The
combined
facilitate
both
anatomical
functional
activity.
This
enables
correlation
signals
with
expression,
radiation
dosage,
intratumor
ROS,
DNA
damage,
enabling
early
prediction
outcomes
(as
3
h),
preceding
size
reduction
(6
days).
By
monitoring
levels,
this
allows
sensitive
detection
liver
organ
injury,
outperforming
histopathological
analysis.
Furthermore,
evaluates
expression
radiation-induced
abscopal
effects
provides
insights
into
underlying
mechanisms,
supports
development
treatment
protocols.
are
promising
radiotherapy,
but
normally
detect
authors
report
ACS Nano,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 31, 2024
The
comprehensive
evaluation
of
tumor
vasculature
that
is
crucial
for
the
development,
expansion,
and
spread
cancer
still
remains
a
great
challenge,
especially
three-dimensional
(3D)
vasculatures.
In
this
study,
we
proposed
magnetic
resonance
(MR)
angiography
strategy
with
interlocking
stratagem
zwitterionic
Gd-chelate
contrast
agents
(PAA-Gd)
continuous
monitoring
angiogenesis
progression
in
3D.
Owing
to
structure
nanoscale
molecular
diameter,
longitudinal
molar
relaxivity
(r1)
PAA-Gd
was
2.5
times
higher
than
individual
Gd-chelates
on
7.0
T
MRI
scanner,
resulting
higher-resolution
visualization
More
importantly,
has
appropriate
blood
half-life
(69.2
min),
emphasizing
extended
imaging
window
compared
Gd-chelates.
On
basis,
by
using
as
agent,
high-resolution,
3D
depiction
spatiotemporal
distribution
microvasculature
solid
tumors
formed
different
cell
lines
over
various
inoculation
been
obtained.
This
method
offers
an
effective
approach
early
diagnosis,
development
assessment,
prognosis
evaluation.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
Amplification
of
lipid
peroxidation
with
tumor
specificity
represents
a
new
avenue
to
boost
ferroptosis-mediated
anticancer
therapeutics
but
remains
challenging.
Herein,
we
proposed
metal-phenolic-network
(MPN)-coated
nanohybrid
as
microenvironment-responsive
amplifier,
consisting
reactive
oxygen
species
generator
MPN,
glutathione
(GSH)
scavenger
GSH-P,
and
peroxidase
4
(GPX4)
mRNA
gene
silencing
sequence.
The
protective
MPN
shell
this
amplifier
can
be
specifically
disintegrated
by
acidic
adenosine
triphosphate
(ATP)-rich
microenvironments
induce
oxidative
stress
through
the
dual
disruption
redox
homeostasis
(Fenton-catalytic
accumulation
GSH
depletion).
Furthermore,
stress-induced
upregulation
ferroptosis
resistance-related
apurinic/apyrimidinic
endonuclease
1
(APE1)
is
further
ingeniously
employed
an
amplification
element
prompt
release
(AP)
site-embedded
GPX4
sequence
which
downregulate
level.
Based
on
tandem
depletion
substrate
GPX4,
defense
system
GPX4/GSH
heavily
devastated
enable
for
effectively
improving
efficiency.
We
expect
strategy
expanded
other
important
regulatory
proteins
provide
mechanism
study
therapy.